ImmunoPrecise Antibodies Ltd.(TSX Venture Exchange : IPA)
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-7.49%||11.86||0.7%||$829.06m|
|VRTX||Vertex Pharmaceuticals, Inc.||0.23%||188.13||1.9%||$535.32m|
|GILD||Gilead Sciences, Inc.||-0.46%||67.04||1.0%||$495.71m|
|REGN||Regeneron Pharmaceuticals, Inc.||-0.08%||533.84||2.7%||$388.10m|
|ALXN||Alexion Pharmaceuticals, Inc.||-0.58%||179.61||2.0%||$337.94m|
|TXG||10X Genomics, Inc.||0.53%||198.93||0.0%||$178.29m|
|EXAS||EXACT Sciences Corp.||0.66%||128.50||18.1%||$177.57m|
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization. The company was founded by Robert Beecroft on November 22, 1983 and is headquartered in Victoria, Canada.